Amylyx Pharmaceuticals (AMLX) Receivables - Net (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) posted quarterly Receivables - Net of $88000.0 for Q4 2025, down 80.31% year-over-year from $447000.0 in Q4 2024, and down 33.33% quarter-over-quarter from $132000.0 in Q3 2025.
Amylyx Pharmaceuticals (AMLX) Receivables - Net (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Receivables - Net history runs 4 years deep, the most recent figure standing at $88000.0 for Q4 2025.
- In Q4 2025, Receivables - Net fell 80.31% year-over-year to $88000.0; the TTM figure through Dec 2025 stood at $88000.0 (down 80.31% YoY), while the FY2025 annual figure was $88000.0, down 80.31% from the prior year.
- Receivables - Net for Q4 2025 stood at $88000.0, down from $132000.0 in the prior quarter.
- The five-year high for Receivables - Net was $40.0 million in Q4 2023, with the low at $88000.0 in Q4 2025.
- The 4-year median for Receivables - Net is $2.9 million (2024), against an average of $11.7 million.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net surged 21325.55% in 2023, then tumbled 98.88% in 2024.
- Amylyx Pharmaceuticals' Receivables - Net stood at $15.3 million in 2022, then jumped by 161.66% to $40.0 million in 2023, then sank by 98.88% to $447000.0 in 2024, then tumbled by 80.31% to $88000.0 in 2025.
- Business Quant data shows AMLX's Receivables - Net at $88000.0 in Q4 2025, $132000.0 in Q3 2025, and $103000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.36 Bn | 4.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 20.35 Mn |
| Mar 31, 2024 | 20.35 Mn |
| Dec 31, 2023 | 40.05 Mn |
| Dec 31, 2023 | 40.05 Mn |
| Sep 30, 2023 | 29.35 Mn |
| Sep 30, 2023 | 29.35 Mn |